Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Clinical trial NCT00065442 · COMPLETED

Trial details

NCT number: NCT00065442
Sponsor: Dendreon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2003-07-01
Primary completion: 2009-01-01
Enrollment: 512

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.